← Other psychedelics

2C-I

4-Iodo-2,5-dimethoxyphenethylamine

A less-studied psychedelic associated with visual change and stimulation.

C₁₀H₁₄INO₂View molecular structure

2C-I is a synthetic member of the 2C family. The I refers to iodine in its molecular structure.

It appears in psychonaut writing alongside 2C-B and 2C-E, but its own evidence base is small.

2C-I at a glance

Family
Phenethylamines · 2C family
Type
Serotonergic psychedelic
Primary target
5-HT2A
Onset (oral)
Variable; limited controlled data
Duration (oral)
Reported 6–10 hours
Origin
Synthetic

What is 2C-I?

2C-I belongs to the substituted phenethylamines and acts at serotonin receptors associated with psychedelic effects. 5-HT2A is a central part of that mechanism.

It is chemically distinct from 25I-NBOMe. The presence of iodine in both names does not make these compounds equivalent.

The 2C-I experience

Sensory effects

Firsthand reports describe enhanced colour and visual patterns. Some emphasise sensory changes more than emotional depth, although this distinction is inconsistent.

Auditory effects are less clearly documented. There is not enough controlled evidence to describe a dependable pattern of changes to sound.

Body sensations

A noticeable stimulating quality is often reported. Tension, nausea and unfamiliar bodily sensations may accompany the perceptual effects.

Headspace

Attention and associations can feel unusual. Accounts include excitement as well as anxiety, but the small evidence base makes confident comparisons with 2C-B or 2C-E unreliable.

Self, time and space

Time perception may change, and surroundings can feel unfamiliar. More detailed claims about identity or ego dissolution rest on limited accounts rather than a well-established human profile.

History and culture

2C-I was documented in PiHKAL as part of the Shulgins’ exploration of phenethylamines. Its later circulation helped bring it into online discussion of less familiar psychedelics.

The resulting archive contains useful observations, but often lacks verified identity, medical follow-up or a consistent way of recording effects.

Research and uses

Laboratory studies of receptor activity help explain why compounds in this family can alter perception. That is different from demonstrating a safe or effective human treatment.

Evidence about long-term outcomes and therapeutic applications of 2C-I remains limited. Findings from other psychedelics cannot fill every gap.

Risks and considerations

Physical stimulation may include increased heart rate and blood pressure. Distress, confusion and other adverse reactions are possible, with limited evidence to quantify their frequency.

Confusion with similarly named compounds is particularly important. 25I-NBOMe has a different potency and risk profile, and visual appearance cannot distinguish them reliably.

FAQ

Is 2C-I the same as 25I-NBOMe?

No. They are distinct molecules with materially different pharmacology and risks.

Does iodine make it radioactive?

No. The presence of iodine in a chemical name does not imply radioactivity.

How certain are descriptions of its effects?

They rely heavily on personal accounts and limited research, so confident comparisons deserve caution.

Sources
  1. Shulgin and Shulgin: PiHKAL, 2C-I
  2. Receptor activity of 2C and NBOMe compounds
  3. PubChem: 2C-I molecular identity